100 related articles for article (PubMed ID: 5317363)
1. Cryoprecipitated factor VIII concentrate.
Pool JG
Thromb Diath Haemorrh Suppl; 1968; 35():35-40. PubMed ID: 5317363
[No Abstract] [Full Text] [Related]
2. Storage of thawed cryoprecipitated AHF is better at room temperature than at 1 degree C to 6 degrees C for factor VIII content.
Saxena S; Odono V; Francis R; Shulman IA
Arch Pathol Lab Med; 1991 Apr; 115(4):343-5. PubMed ID: 1901483
[TBL] [Abstract][Full Text] [Related]
3. Survival of iodine-125-labeled factor VIII in patients with von Willebrand's disease.
Over J; Sixma JJ; Bouma BN; Bolhuis PA; Vlooswijk RA; Beeser-Visser NH
J Lab Clin Med; 1981 Mar; 97(3):332-44. PubMed ID: 6780640
[No Abstract] [Full Text] [Related]
4. [Value of cryoprecipitate in the treatment of von Willebrand's disease].
Dyszy-Laube B; Zywicka-Lopaciuk H; Lopaciuk S
Pediatr Pol; 1970 Aug; 45(8):911-5. PubMed ID: 5311867
[No Abstract] [Full Text] [Related]
5. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.
Gazengel C; Fischer AM; Schlegel N; Rothschild C; Torchet MF; Dautzenberg MD; Aujard Y
Nouv Rev Fr Hematol (1978); 1988; 30(4):225-7. PubMed ID: 3143100
[TBL] [Abstract][Full Text] [Related]
6. Utilization of the residual plasma following preparation of factor VIII cryoprecipitate.
Oberman HA; Penner JA
JAMA; 1968 Sep; 205(12):819-21. PubMed ID: 5695503
[No Abstract] [Full Text] [Related]
7. A new method of demonstrating the effect of therapy in von Willebrand's disease.
Sutor AH; Bowie EJ; Owen CA
Mayo Clin Proc; 1971 May; 46(5):345-6. PubMed ID: 5314172
[No Abstract] [Full Text] [Related]
8. Correction by factor VIII of decreased neutrophil alkaline phosphatase activity in classic haemophilia and von Willebrand's disease.
Janković GM; Janosević S
Haematologia (Budap); 1978-1979; 12(1-4):183-8. PubMed ID: 317061
[TBL] [Abstract][Full Text] [Related]
9. Concentrated antihemophilic factor (AHF) from outdated blood.
Weaver RA; Gabriel DA; Langdell RD
Transfusion; 1967; 7(3):168-73. PubMed ID: 6025692
[No Abstract] [Full Text] [Related]
10. Glycine-precipitated antihemophilic factor concentrates and their clinical use.
Wagner RH; Roberts HR; Webster WP; Shanbrom E; Brinkhous KM
Thromb Diath Haemorrh Suppl; 1968; 35():41-8. PubMed ID: 5761073
[No Abstract] [Full Text] [Related]
11. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
Mason EC; Pepper DS; Griffin B
Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic materials used in the treatment of coagulation defects.
Smith JK; Bidwell E
Clin Haematol; 1979 Feb; 8(1):183-206. PubMed ID: 367662
[No Abstract] [Full Text] [Related]
13. Factor VIII (antihemophilic globulin).
Aronson DL
Semin Thromb Hemost; 1979; 6(1):12-27. PubMed ID: 390712
[No Abstract] [Full Text] [Related]
14. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
Sultan Y; Simeon J; Maisonneuve P; Caen JP
Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
[TBL] [Abstract][Full Text] [Related]
15. Cryoprecipitated factor 8 concentrate.
Pool JG
Bibl Haematol; 1970; 34():23-9. PubMed ID: 5436350
[No Abstract] [Full Text] [Related]
16. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
[TBL] [Abstract][Full Text] [Related]
17. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A
J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302
[TBL] [Abstract][Full Text] [Related]
18. Treatment of congenital deficiencies of factor VIII and factor IX.
Rizza CR; Biggs R
Thromb Diath Haemorrh Suppl; 1968; 35():73-84. PubMed ID: 5317365
[No Abstract] [Full Text] [Related]
19. Preparation and testing of antihemophilic globulin (Factor 8) sources for transfusion therapy in hemophilia. Description of a new sterile concentrate process for blood banks.
Pool JG
Scand J Clin Lab Invest; 1965; 17():Suppl 84:70-7. PubMed ID: 5862567
[No Abstract] [Full Text] [Related]
20. [Hemotherapy in blood coagulation disorders].
Griffitts JJ
Bibl Haematol; 1967; 27():294-6. PubMed ID: 5317772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
